Collectively these results unveil a novel role for SRSF3 and hnRNPM in the regulation of DHX9 alternative splicing, which also impacts on Ewing sarcoma cell sensitivity to chemotherapeutic treatments. The gene discussed is DHX9; the disease is Ewing sarcoma.